Journal
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Volume 8, Issue 4, Pages 212-244Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/15622970701685224
Keywords
borderline personality disorder; schizotypal personality disorder; anxious/avoidant personality disorder; evidence-based guidelines; biological treatment; pharmacotherapy; antidepressants; neuroleptics; mood stabilizer
Categories
Ask authors/readers for more resources
These practical guidelines for the biological treatment of personality disorders in primary care settings were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). They embody the results of a systematic review of all available clinical and scientific evidence pertaining to the biological treatment of three specific personality disorders, namely borderline, schizotypal and anxious/avoidant personality disorder in addition to some general recommendations for the whole field. The guidelines cover disease definition, classification, epidemiology, course and current knowledge on biological underpinnings, and provide a detailed overview on the state of the art of clinical management. They deal primarily with biological treatment (including antidepressants, neuroleptics, mood stabilizers and some further pharmacological agents) and discuss the relative significance of medication within the spectrum of treatment strategies that have been tested for patients with personality disorders, up to now. The recommendations should help the clinician to evaluate the efficacy spectrum of psychotropic drugs and therefore to select the drug best suited to the specific psychopathology of an individual patient diagnosed for a personality disorder.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available